Get to know us
About Us
Established in 2017, CUTISS is a spin-off from University of Zurich (UZH) / Children’s Hospital and a member of the accelerator Wyss Zurich. Headquartered at the Bio-Technopark in Zurich, it won the Top 100 Swiss Startup Award 2020, and has raised about CHF 50 million from private investors, family offices and public bodies.
The team of CUTISS AG includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
Get to know us
About Us
Established in 2017, CUTISS is a spin-off from University of Zurich (UZH) / Children’s Hospital and a member of the accelerator Wyss Zurich. Headquartered at the Bio-Technopark in Zurich, it won the Top 100 Swiss Startup Award 2020, and has raised about CHF 50 million from private investors, family offices and public bodies.
The team of CUTISS AG includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
Management
Dr. Daniela
Marino
Member of Board of Directors
Dr. Fabienne Hartmann-Fritsch
Co-Founder
Dr. Vincent
Ronfard
Officer
Kathi
Mujynya Ludunge
Officer
Peter
Harboe-Schmidt
Officer
Board of Directors
Prof. Martin
Meuli
Co-Founder
Giammaria
Giuliani
BoD
Prof. Ernst
Reichmann
Co-Founder
Dr. Daniela
Marino
Co-Founder
Dr. Gérard
Ber
Member of the BoD
Secretary to the Board of Directors
Ralf
Rosenow
Founding Team
Cutiss Founders
PD Dr. med. Clemens Schiestl, Prof. Dr. Ernst Reichmann, Prof. Dr. med. Martin Meuli, Dr. sc. Daniela Marino, Dr. sc. nat. Fabienne Hartmann-Fritsch
